Magaia, Mário;
Magaia, Célia C;
Couto, Aleny;
Dengo, Nataniel;
Cassamo, Abdul R;
Nhantumbo, Rene;
Mahumane, Carlos;
Mabote, Atanásio;
Mikusova, Silvia;
Nhangave, Amâncio;
Bhatt, Nilesh;
Mukherjee, Sushant S.
In Mozambique, 38.7% of women and 60.4% of men ages 15–59 years old living with HIV
do not know their HIV status. A pilot home-based HIV counseling and testing program
based on index cases in the community was implemented in eight districts in Gaza province
(Mozambique). The pilot targeted the sexual p...
Background: The entire population of Mozambique is at risk for malaria, which remains one of the leading causes of death. The 2017-2022 National Malaria Strategic Plan focuses on reducing malaria morbidity and mortality in high- and low-transmission areas. This study aimed to estimate the costs and healt...
Background: As malaria cases increase in some of the highest burden countries, more strategic deployment of new and proven interventions must be evaluated to meet global malaria reduction goals.
Methods: The cost and cost-effectiveness of indoor residual spraying (IRS) with pirimiphos-methyl (Actellic®3...
Background: It is frequently said that funding is essential to ensure optimal results from a malaria intervention control. However, in recent years, the capacity of the government of Mozambique to sustain the operational cost of indoor residual spraying (IRS) is facing numerous challenges due to restrict...
Ciera, Leia;
Galatas, Beatriz;
Alonso, Sergi;
Peaijimas, Krijin;
Mamuque, Miler;
Marti-Solar, Helena;
Guinovart, Caterina;
Munguambe, Humberto;
Luis, Fabiao;
Nhantumbo, Hoticha;
Montana, Julia;
Bassat, Quique;
Candrinho, Baltazar.
As new combinations of interventions aiming at interrupting malaria transmission are under evaluation, understanding the associated economic costs and benefits is critical for decision-making. This study assessed the economic cost and cost-effectiveness of the Magude project, a malaria elimination initia...
Philips, Andrew N;
Cambiano, Valentina;
Nakagawa, Fumiyo;
Matharu, Loveleen Bansi;
Wilson, David;
Jani, Ilesh;
Apollo, Tsitsi;
Sculpher, Mark;
Hallett, Timothy;
Kerr, Cliff 2 7;
Ooterhout, Joep J van;
Eaton, Jeffrey W;
Estill, Janne 10 11;
Williams, Brian;
Doi, Naoko;
Cowan, Frances;
Keiser, Olivia;
Ford, Deborah;
Hatzold, Karin;
Barnabas, Ruanne;
Ayles, Helen;
Rath, Gesine Meyer;
Nelson, Lisa;
Johnson, Cheryl;
Baggaley, Rachel;
Fakoya, Ade;
Jahn, Andreas;
Revill, Paul.
Introduction: As prevalence of undiagnosed HIV declines, it is unclear whether testing programmes will be cost-effective. To guide their HIV testing programmes, countries require appropriate metrics that can be measured. The cost-per-diagnosis is potentially a useful metric.
Methods: We simulated a serie...
Africa, Southern,
Circumcision, Male,
d0000829220,
Cost-Benefit Analysis,
HIV Infections/diagnosis,
HIV Infections/epidemiology,
HIV-1,
Mass Screening/economics,
Poverty,
Pregnancy,
Risk Factors,
Sex Workers
Orlando, s;
Triulzi, i;
Ciccacci, f;
Palla, i;
Palombi, l;
Marazzi, m c;
Giuliano, m;
Floridia, m;
Mancinelli, s;
Mutemba, e;
Turchetti, g.
Background: Tuberculosis (TB) represents the ninth leading cause of death worldwide. In 2016 are estimated 1.3 million TB deaths among HIV negative people and an additional 374,000 deaths among HIV positive people. In 2016 are estimated 1.4 million new cases of TB in people living with HIV (PLHIV), 74% o...
Comorbidity,
Cost-Benefit Analysis,
Delayed Diagnosis,
Diagnostic Tests, Routine/methods,
HIV Infections/diagnosis,
HIV Infections/epidemiology,
HIV Infections/therapy,
Mass Screening/methods,
Reproducibility of Results,
Tuberculosis/epidemiology,
Tuberculosis/diagnosis,
Tuberculosis/therapy,
Mozambique/epidemiology,
High-Throughput Screening Assays/economics,
Mozambique
Introduction: The scale-up of effective HIV viral load (VL) testing is an urgent public health priority. Implementation of testing is supported by the availability of accurate, nucleic acid based laboratory and point-of-care (POC) VL technologies and strong WHO guidance recommending routine testing to id...
Hyle, emily, p;
Jani, ilesh, v;
Lehe, jonathan;
Su, amanda, e;
Wood, robin;
Quevedo, jorge;
Losina, elena;
Bassett, ingrid, v;
Pei, pamela, p;
Paltiel, a, david;
Resch, stephen;
Freedberg, kenneth, a;
Peter, trevor;
Walensky, rochelle, p.
Background: Point-of-care CD4 tests at HIV diagnosis could improve linkage to care in resource-limited settings. Our objective is to evaluate the clinical and economic impact of point-of-care CD4 tests compared to laboratory-based tests in Mozambique.
Methods and findings: We use a validated model of HIV...
CD4 Lymphocyte Count/economics,
CD4 Lymphocyte Count/methods,
Cost-Benefit Analysis/economics,
Cost-Benefit Analysis/methods,
HIV Infections/diagnosis,
HIV Infections/epidemiology,
HIV Infections/economics,
Health Care Costs,
Health Resources/economics,
Mozambique/epidemiology,
Point-of-Care Systems/economics
The scale-up of effective HIV viral load (VL) testing is an urgent public health priority. Implementation of testing
is supported by the availability of accurate, nucleic acid based laboratory and point-of-care (POC) VL technologies and strong
WHO guidance recommending routine testing to identify treatme...
